Calliditas Therapeutics Adr Rep 2 Ord Shs CALT

Healthcare

Calliditas Therapeutics AB, formerly Pharmalink AB, is a Sweden-based specialty pharmaceutical company. It is focused on the development and commercialization of its product candidate Nefecon, a treatment for patients with inflammatory kidney disease (IgA nephropathy) who are at risk of progressing to renal failure. Nefecon is derived from the TARGIT technology, in which the capsule containing the active drug substance is coated in a way that the capsule remains intact as it passes through the stomach and intestine until it reaches the lower small intestine, where the release of content takes place. Nefeco combines time lag effect with a concentrated release of the active substance budesonide, within a designated target area.

NDAQ:CALT - Post by User

Calliditas Therapeutics Adr Rep 2 Ord Shs

<< Previous

Bullboard Posts

Post by whytestockson Feb 14, 2024 1:30am

43 Views

Post# 35879097

Invitation to the presentation of Calliditas´ Year-end

Just In: $CALT Invitation to the presentation of Calliditas´ Year-end report January - December 2023Invitation to the presentation of Calliditas´ Year-end report January - December 2023 PR Newswire STOCKHOLM , Feb. 14, 2024 /PRNewswire/ -- Calliditas' Year-end report for January - December 2023 will be published in Swedish and English on Wednesday ...CALT - Invitation to the presentation of Calliditas´ Year-end report January - December 2023

<< Previous

Bullboard Posts

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle